These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3265217)

  • 1. [Evaluation of dilated cardiomyopathy and coronary artery disease using positron CT (PCT)].
    Fudo T; Kambara H; Hashimoto T; Hayashi M; Kawai C
    Kokyu To Junkan; 1988 Jun; 36(6):649-53. PubMed ID: 3265217
    [No Abstract]   [Full Text] [Related]  

  • 2. Positron-emission tomography: assessment of myocardial blood flow and metabolism.
    Schelbert HR
    Circulation; 1985 Nov; 72(5 Pt 2):IV122-33. PubMed ID: 3902283
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitation of regional myocardial blood flow in coronary microvascular disease.
    Neglia D; Sambuceti G; Palombo C; Marabotti C; Riva A; Puccini G; Parodi O
    J Nucl Biol Med (1991); 1992; 36(2 Suppl):41-51. PubMed ID: 1450244
    [No Abstract]   [Full Text] [Related]  

  • 4. The Mikamo lecture. Probing the heart's biochemistry with positron emission tomography.
    Schelbert HR
    Jpn Circ J; 1986 Jan; 50(1):1-29. PubMed ID: 3486300
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of myocardial viability with positron emission tomography in a patient with ischemic cardiomyopathy.
    J Nucl Med; 1991 Jan; 32(1):130-5. PubMed ID: 1988617
    [No Abstract]   [Full Text] [Related]  

  • 6. Positron tomography and myocardial metabolism: an overview.
    Sobel BE
    Circulation; 1985 Nov; 72(5 Pt 2):IV22-30. PubMed ID: 3931935
    [No Abstract]   [Full Text] [Related]  

  • 7. Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomography.
    Mody FV; Brunken RC; Stevenson LW; Nienaber CA; Phelps ME; Schelbert HR
    J Am Coll Cardiol; 1991 Feb; 17(2):373-83. PubMed ID: 1991893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [123I-metaiodobenzylguanidine myocardial images for assessment of sympathetic nervous system in the heart].
    Tanaka T; Aizawa T; Kato K
    Kokyu To Junkan; 1991 Aug; 39(8):755-66. PubMed ID: 1925097
    [No Abstract]   [Full Text] [Related]  

  • 9. [Differentiation of ischemic cardiomyopathy from idiopathic dilated cardiomyopathy. Evaluation of the value of radionuclide imaging].
    Kurihara T; Narita M; Murano K; Usami M; Honda M; Kanao K
    Kaku Igaku; 1985 Jan; 22(1):49-55. PubMed ID: 3999455
    [No Abstract]   [Full Text] [Related]  

  • 10. Positron emission tomography is a useful tool in differentiating idiopathic from ischemic dilated cardiomyopathy.
    Boff GM; Zanco P; Della Valentina P; Cardaioli P; Thiene G; Chioin R; Dalla Volta S
    Int J Cardiol; 2000 Jun; 74(1):67-74; discussion 75-6. PubMed ID: 10854681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Positron emission tomography (PET)].
    Tamaki N; Morita K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():377-86. PubMed ID: 12735002
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of myocardial glucose utilization of hypertrophic and dilated cardiomyopathy using 18F-2-fluoro 2-deoxy-D-glucose and positron emission tomography].
    Ohtake T; Kosaka N; Watanabe T; Momose T; Nishikawa J; Sasaki Y; Iio M; Yokoyama I; Iizuka M; Sugimoto T
    Nihon Rinsho; 1991 Jan; 49(1):143-7. PubMed ID: 2002593
    [No Abstract]   [Full Text] [Related]  

  • 13. Insights into coronary artery disease gained from metabolic imaging.
    Schelbert HR; Buxton D
    Circulation; 1988 Sep; 78(3):496-505. PubMed ID: 3044639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Positron computed tomography of the heart].
    Yoshida K; Masuda Y; Yamazaki T; Tateno Y
    Kokyu To Junkan; 1984 Mar; 32(3):241-8. PubMed ID: 6610906
    [No Abstract]   [Full Text] [Related]  

  • 15. [Differential x-ray diagnosis of congestive cardiomyopathy and ischemic heart disease].
    Matveeva LS; Mukharliamov NM; Kitaeva IT; Fedorov AIu
    Ter Arkh; 1984; 56(4):101-4. PubMed ID: 6233743
    [No Abstract]   [Full Text] [Related]  

  • 16. [The present status of clinical nuclear cardiology].
    Nishimura T
    Rinsho Hoshasen; 1986 Sep; 31(9):983-92. PubMed ID: 3491235
    [No Abstract]   [Full Text] [Related]  

  • 17. [Principles and applications of positron emission tomography (PET) in cardiology. PET in Mexico: a reality].
    Alexanderson Rosas E; Kerik NE; Unzek Freiman S; Fermon Schwaycer S
    Arch Cardiol Mex; 2002; 72(2):157-64. PubMed ID: 12148336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myocardial positron emission tomography (PET) with fluorodeoxyglucose-18F].
    Grupo PET de la SEMN
    Rev Esp Med Nucl; 2002 Jul; 21(4):301-3. PubMed ID: 12206747
    [No Abstract]   [Full Text] [Related]  

  • 19. [Radionuclide assessment of myocardial failure: importance of metabolic mapping].
    Nishimura T; Nagata S; Uehara T; Shimonagata T; Miyatake K
    Jpn Circ J; 1992; 56 Suppl 5():1291-3. PubMed ID: 1291711
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative analysis of parametric images in patients with dilated cardiomyopathy and coronary heart disease by radionuclide ventriculography].
    Ostroumov EN; Naumov VG; Saidova MA; Ustiugova LM; Nasonova TI; Korolev SV; Sergienko VB; Mukharliamov NM
    Ter Arkh; 1990; 62(12):24-8. PubMed ID: 2084916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.